Clinical Trials Logo

First or Second Relapse clinical trials

View clinical trials related to First or Second Relapse.

Filter by:
  • None
  • Page 1

NCT ID: NCT01217203 Completed - Clinical trials for Patients With Multiple Myeloma Experiencing a

Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse

KIRIMID
Start date: September 2010
Phase: Phase 1
Study type: Interventional

The primary objective of the clinical study is to evaluate, in patients who experience a first or second relapse of their multiple myeloma, the safety of escalating doses of IPH2101 combined with lenalidomide